Global Medical REIT Inc. (GMRE)
NYSE: GMRE · Real-Time Price · USD
32.35
-0.34 (-1.04%)
Dec 5, 2025, 4:00 PM EST - Market closed
Global Medical REIT Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Global Medical REIT stock ranges from a low of $40 to a high of $41. The average analyst price target of $40.5 forecasts a 25.19% increase in the stock price over the next year.
Price Target: $40.50 (+25.19%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Global Medical REIT stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 0 | 0 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 3 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Hold Maintains $45 → $41 | Hold | Maintains | $45 → $41 | +26.74% | Nov 11, 2025 |
| JMP Securities | JMP Securities | Hold → Buy Upgrades $40 | Hold → Buy | Upgrades | $40 | +23.65% | Oct 13, 2025 |
| Baird | Baird | Hold Maintains $50 → $45 | Hold | Maintains | $50 → $45 | +39.10% | May 8, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 12, 2025 |
| Berenberg | Berenberg | Strong Buy Initiates $59 | Strong Buy | Initiates | $59 | +81.61% | Oct 18, 2024 |
Financial Forecast
Revenue This Year
149.15M
from 138.76M
Increased by 7.49%
Revenue Next Year
153.89M
from 149.15M
Increased by 3.18%
EPS This Year
0.28
from 0.06
Increased by 353.34%
EPS Next Year
0.12
from 0.28
Decreased by -58.54%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 154.6M | 161.6M | ||
| Avg | 149.2M | 153.9M | ||
| Low | 140.1M | 146.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 11.4% | 8.4% | ||
| Avg | 7.5% | 3.2% | ||
| Low | 1.0% | -2.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.37 | 0.42 | |
| Avg | 0.28 | 0.12 | |
| Low | 0.15 | -0.12 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 497.6% | 50.6% | |
| Avg | 353.3% | -58.5% | |
| Low | 139.0% | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.